Diagnostic Industry

Leading in vitro diagnostic and diagnostic imaging companies have revolutionized disease detection. Staying up to date on newest trends, technology, best practices and regulations is crucial to advance in the industry.

Diagnostic Industry

The diagnostic industry, which is responsible for testing patients to detect disease, is estimated to have a global worth of US$ 40–45 billion. The industry is made up of three main segments. The first, and most profitable segment is In Vitro Diagnostics (IVD) and biotech diagnostics, which involves testing samples of blood and tissue. The second is Diagnostic Imaging, which involves x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI). The third is Testing Techniques, such as HIV testing, HPV testing, hepatitis testing or drug testing.

There has been a recent shift in the diagnostic industry in response to an increased demand for quick and accurate viral testing. Manufacturers have recently restructured to make testing technologies, products, reagents, and assays based on an open-source platform. This new model allows manufacturers to offer testing for a larger population with a quicker, more accurate turnaround.

Q1 Productions provides custom-tailored event programming that offers an in-depth view of the current diagnostic market, emerging key players in the industry, and important developing trends. Both virtual and in-person events deliver unique engagement experiences to captivate attendees. Smart, innovative technology, audio, visual, and interactive elements to make attendees’ experiences notable and insightful. Event programming is less broad than other diagnostics industry events and focus on specific subjects developed by industry leaders.

If you are interested in future events, click here to see our forward calendar.

Latest News from our Diagnostic Blog